Statin therapy for primary prevention of cardiovascular disease.
Fiona C Taylor;
Mark Huffman;
Shah Ebrahim;
(2013)
Statin therapy for primary prevention of cardiovascular disease.
JAMA, 310 (22).
pp. 2451-2452.
ISSN 0098-7484
DOI: 10.1001/jama.2013.281348
CLINICAL QUESTION: Do statins reduce rates of cardiovascular events when used for primary prevention? BOTTOM LINE: When used for primary prevention, statins are associated with lower rates of all-cause mortality, major vascular events, and revascularizations compared with placebo. Statin therapy is not associated with increased rates of life-threatening adverse effects such as cancer.
| Item Type | Article |
|---|---|
| ISI | 328030900026 |